These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities. Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000 [TBL] [Abstract][Full Text] [Related]
23. Low-Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System. Mafi JN; May FP; Kahn KL; Chong M; Corona E; Yang L; Mongare MM; Nair V; Reynolds C; Gupta R; Damberg CL; Esrailian E; Sarkisian C J Am Geriatr Soc; 2019 Dec; 67(12):2600-2604. PubMed ID: 31486549 [TBL] [Abstract][Full Text] [Related]
24. The use of proton pump inhibitors in an Italian hospital: focus on oncologic and critical non-ICU patients. Meli M; Raffa MP; Malta R; Morreale I; Aprea L; D'Alessandro N Int J Clin Pharm; 2015 Dec; 37(6):1152-61. PubMed ID: 26319396 [TBL] [Abstract][Full Text] [Related]
25. Inappropriate use of proton pump inhibitors in a local setting. Chia CT; Lim WP; Vu CK Singapore Med J; 2014 Jul; 55(7):363-6. PubMed ID: 25091884 [TBL] [Abstract][Full Text] [Related]
26. [Current use of proton pump inhibitors and when to limit, stop or not start treatment]. Helgadottir H; Bjornsson ES Laeknabladid; 2023 Jul; 109(708):338-345. PubMed ID: 37378651 [TBL] [Abstract][Full Text] [Related]
27. Proton pump inhibitors: use and misuse in the clinical setting. Savarino V; Marabotto E; Zentilin P; Furnari M; Bodini G; De Maria C; Pellegatta G; Coppo C; Savarino E Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1123-1134. PubMed ID: 30295105 [TBL] [Abstract][Full Text] [Related]
28. Deprescribing proton pump inhibitors. Turner JP; Thompson W; Reeve E; Bell JS Aust J Gen Pract; 2022 Nov; 51(11):845-848. PubMed ID: 36310001 [TBL] [Abstract][Full Text] [Related]
29. Proton pump inhibitors, adverse events and increased risk of mortality. Lanas-Gimeno A; Hijos G; Lanas Á Expert Opin Drug Saf; 2019 Nov; 18(11):1043-1053. PubMed ID: 31498687 [No Abstract] [Full Text] [Related]
30. Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation. Giannini EG; Crespi M; Djahandideh A; Demarzo MG; Moscatelli A; Bodini G; Furnari M; Marabotto E; Plaz Torres MC; Zentilin P; Savarino V Dig Liver Dis; 2020 Aug; 52(8):862-868. PubMed ID: 32505566 [TBL] [Abstract][Full Text] [Related]
31. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease. Higginbotham TW Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466 [TBL] [Abstract][Full Text] [Related]
32. [Proton-pump inhibitors treatment. Does your patient really need it?]. Fuentes-Valenzuela E; Díez Redondo P; Tejedor-Tejada J; Nájera-Muñoz R; Sánchez-Delgado L; Maroto-Martín C Semergen; 2022 Mar; 48(2):82-87. PubMed ID: 34728148 [TBL] [Abstract][Full Text] [Related]
33. Inappropriate prescribing of proton pump inhibitors in older patients: effects of an educational strategy. Hamzat H; Sun H; Ford JC; Macleod J; Soiza RL; Mangoni AA Drugs Aging; 2012 Aug; 29(8):681-90. PubMed ID: 22775478 [TBL] [Abstract][Full Text] [Related]
34. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study. Liu Y; Zhu X; Li R; Zhang J; Zhang F BMJ Open; 2020 Nov; 10(11):e040473. PubMed ID: 33243802 [TBL] [Abstract][Full Text] [Related]
35. The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study. Kelly OB; Dillane C; Patchett SE; Harewood GC; Murray FE Dig Dis Sci; 2015 Aug; 60(8):2280-6. PubMed ID: 25840918 [TBL] [Abstract][Full Text] [Related]
36. Impact of interventions targeting the inappropriate use of proton-pump inhibitors by clinical pharmacists in a hepatobiliary surgery department. Zhang Y; Yang H; Kong J; Liu L; Ran L; Zhang X; Yun J; Gu Q J Clin Pharm Ther; 2021 Feb; 46(1):149-157. PubMed ID: 33015848 [TBL] [Abstract][Full Text] [Related]
37. A questionnaire on prescription patterns of proton pump inhibitors for hemodialysis patients in Japan. Kawarazaki H; Nakashima A; Furusho M; Shimizu S; Nakata T Clin Exp Nephrol; 2020 Jun; 24(6):565-572. PubMed ID: 32147803 [TBL] [Abstract][Full Text] [Related]
38. [Thesaurus of pharmacist interventions associated with inappropriate proton pump inhibitors prescriptions]. Veremme L; Baudouin A; Janoly-Dumenil A; Charpiat B Ann Pharm Fr; 2023 May; 81(3):552-567. PubMed ID: 36375534 [TBL] [Abstract][Full Text] [Related]
39. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study. Lassalle M; Le Tri T; Bardou M; Biour M; Kirchgesner J; Rouby F; Dumarcet N; Zureik M; Dray-Spira R Eur J Clin Pharmacol; 2020 Mar; 76(3):449-457. PubMed ID: 31838548 [TBL] [Abstract][Full Text] [Related]
40. A benefit-risk assessment of the use of proton pump inhibitors in the elderly. Masclee GM; Sturkenboom MC; Kuipers EJ Drugs Aging; 2014 Apr; 31(4):263-82. PubMed ID: 24634248 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]